As an MAH, you are obliged to investigate the alerts triggered by the products you have marketed.  EMVO has prepared a Best Practice Guide to help you in your investigation of the alerts that end users, or you yourself have triggered. In  EMVO’s resource library, you can also find the EMVS Alerts and Notifications guide and other relevant guides.

DMVO is not currently connected to the European alarm monitoring system, EAMS. If you would like to contact us about an alarm, you can email us at info@dmvo.dk. If you use NMVS Alerts, you can document and write to the DMVO secretariat about the individual alerts there.

An MAH/manufacturer who suspects that a pack may be counterfeit is obliged to report this to the Danish Medicines Agency. If a more thorough investigation confirms that the medicine is falsified, this information must also immediately be reported to the Danish Medicines Agency.